3D-visible molecules, batch-locked Certificates of Analysis, third-party HPLC and mass-spec verification. No spreadsheets to parse, no forum cross-checks to settle it — the proof is already on the page.
We built LeoApexBond because peptide shoppers had been handed the wrong homework: receipt-shaped PDFs and forum cross-checks. The lab work was happening, but the visibility was not. We publish the molecule, the certificate, and the partner laboratory so the buyer can verify the work without leaving the page.
Every published vial now ships with a rotatable 3D molecule on the product and verification pages. Structure, side chains, and stereochemistry are inspectable in the browser — turn the camera, look at the carbonyls, send a screenshot to a collaborator.
The CoA ships in the box and lives online at a public URL keyed to the batch number. The same assay the lab signed is what the buyer reads, unredacted, on a page that does not require an account or an email reply.
Every batch is sampled and assayed at an ISO/IEC 17025-accredited partner lab — HPLC for purity, mass spectrometry for identity. We carry the receipt, we do not run the assay in-house and call it independent.
A short note from the team on what we set out to fix, what we will not ship, and why the verification page is open to anyone with a batch number.
We started LeoApexBond because the research peptide market had a pattern we could not stomach: vague purity claims, locked-away Certificates of Analysis, and a wall of stock photography standing in for evidence. Labs that did the work were hiding it, and labs that did not were selling the appearance of it.
So the company was built the other way around. Every batch is synthesized under cGMP-aligned protocols, lyophilized at the source facility, and independently assayed at an ISO/IEC 17025-accredited partner lab. We do not publish a purity number we cannot hand a lab report for, and we do not give the buyer any reason to trust us without one.
We publish every COA on a public verification page so the people buying the compound — not just us — decide whether the assay stands up. If a batch comes back below the purity we promised, it does not ship. If a customer needs a method, a chromatogram, or the name of the lab that ran the assay, we hand it over the same day.
None of this is special the way marketing pages usually mean "special". It is the floor. What we are actually trying to build is a lab people recommend in plain English because the receipts are there when someone asks to see them.
No spreadsheets to parse, no forum cross-checks to settle it. The molecule, the certificate, and the partner lab are already on the page — that is the only way we are willing to ship a research peptide in 2026.
The work is the only moat we have. So we do the work, and then we show it.
— The LeoApexBond lab team · leoapexbond@polsia.app
Not a tagline. Three concrete artifacts we publish for every batch so the buyer can verify the work without a spreadsheet or a forum thread.
Whom we work with, how often we test, and where the line is drawn.
ISO/IEC 17025-accredited independent partner lab. HPLC + mass spectrometry on every batch, identity confirmed against the published reference standard.
Each synthesis gets its own retain vial, its own assay, and its own signed CoA. We never publish a rolling-window purity figure that hides a sub-spec batch behind the average.
Compounds are sold for research and laboratory use only. Not for human consumption, not for veterinary use, not a substitute for medical advice from a licensed clinician.
Thirty-plus research peptides, every batch third-party assayed and traceable on the public verification page. No login, no "upon request" — the document is the product.